Cargando…
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components
BACKGROUND: Transfusion of blood products is a necessary part of successful delivery of myelosuppressive regimens in pediatric cancer. There is a paucity of literature characterizing outcomes or management of pediatric patients with cancer when transfusion is declined. AIMS: The objective of this pa...
Autores principales: | Stevenson, Jason, DeGroote, Nicholas P., Keller, Frank, Brock, Katharine E., Bergsagel, D. John, Miller, Tamara P., Cornwell, Patricia, Fasano, Ross, Chonat, Satheesh, Castellino, Sharon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875642/ https://www.ncbi.nlm.nih.gov/pubmed/35792092 http://dx.doi.org/10.1002/cnr2.1665 |
Ejemplares similares
-
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020) -
4396 Immunoglobulin administration and hypogammaglobulinemia during pediatric acute leukemia therapy
por: Edington, Holly, et al.
Publicado: (2020) -
Evaluating palliative opportunities in pediatric patients with leukemia and lymphoma
por: Labudde, Emily J., et al.
Publicado: (2021) -
Association of a pediatric palliative oncology clinic on palliative care access, timing and location of care for children with cancer
por: Brock, Katharine E., et al.
Publicado: (2020) -
181 Evaluating the Association of Age with Acuity and Severity of Illness at Initial Clinical Presentation in Patients with Leukemia and Lymphoma
por: Jain, Tarun, et al.
Publicado: (2023)